176 related articles for article (PubMed ID: 32591223)
1. Interferon, restriction factors and SUMO pathways.
El-Asmi F; McManus FP; Thibault P; Chelbi-Alix MK
Cytokine Growth Factor Rev; 2020 Oct; 55():37-47. PubMed ID: 32591223
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense.
Chelbi-Alix MK; Thibault P
Front Cell Dev Biol; 2021; 9():671067. PubMed ID: 33968942
[TBL] [Abstract][Full Text] [Related]
3. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
4. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
5. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
6. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
[TBL] [Abstract][Full Text] [Related]
7. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
9. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between SUMOylation and ISGylation in response to interferon.
El-Asmi F; McManus FP; Brantis-de-Carvalho CE; Valle-Casuso JC; Thibault P; Chelbi-Alix MK
Cytokine; 2020 May; 129():155025. PubMed ID: 32044670
[TBL] [Abstract][Full Text] [Related]
11. Rhabdoviruses, Antiviral Defense, and SUMO Pathway.
El Asmi F; Brantis-de-Carvalho CE; Blondel D; Chelbi-Alix MK
Viruses; 2018 Dec; 10(12):. PubMed ID: 30513968
[TBL] [Abstract][Full Text] [Related]
12. Stability of Smyd1 in endothelial cells is controlled by PML-dependent SUMOylation upon cytokine stimulation.
Becker S; Steinemann G; Karle W; Roos K; Liem CH; Muralikumar S; Volkamer A; Munz B; Zakrzewicz A; Berkholz J
Biochem J; 2021 Jan; 478(1):217-234. PubMed ID: 33241844
[TBL] [Abstract][Full Text] [Related]
13. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection.
Ribet D; Lallemand-Breitenbach V; Ferhi O; Nahori MA; Varet H; de Thé H; Cossart P
mBio; 2017 Jan; 8(1):. PubMed ID: 28074026
[TBL] [Abstract][Full Text] [Related]
15. Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
Jan Fada B; Kaadi E; Samrat SK; Zheng Y; Gu H
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295906
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease.
Berkholz J; Karle W
Cell Signal; 2024 Jul; 119():111156. PubMed ID: 38574938
[TBL] [Abstract][Full Text] [Related]
18. Small ubiquitin-related modifier (SUMO) pathway-mediated enhancement of human cytomegalovirus replication correlates with a recruitment of SUMO-1/3 proteins to viral replication compartments.
Scherer M; Reuter N; Wagenknecht N; Otto V; Sticht H; Stamminger T
J Gen Virol; 2013 Jun; 94(Pt 6):1373-1384. PubMed ID: 23407422
[TBL] [Abstract][Full Text] [Related]
19. SUMO and Cytoplasmic RNA Viruses: From Enemies to Best Friends.
El Motiam A; Vidal S; Seoane R; Bouzaher YH; González-Santamaría J; Rivas C
Adv Exp Med Biol; 2020; 1233():263-277. PubMed ID: 32274761
[TBL] [Abstract][Full Text] [Related]
20. The implication of SUMO in intrinsic and innate immunity.
Hannoun Z; Maarifi G; Chelbi-Alix MK
Cytokine Growth Factor Rev; 2016 Jun; 29():3-16. PubMed ID: 27157810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
